pharmaceutical | Financial Buzz- Part 2

Biotechnology Breaking News Healthcare Market News Technology The Market Buzz

Breaking News: Mydecine Innovations Group Shares Intellectual Property Update

financial buzz01/07/2021

6013

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Hoth Therapeutics (NASDAQ: HOTH) Production of HT-001 for Cancer Treatment

financial buzz12/31/2020

16837

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Hoth Therapeutics Skyrockets Amid Production of its HT-001 for Cancer Treatment” Hoth Therapeutics (NASDAQ: HOTH) shot up over...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Johnson & Johnson Enlists 45,000 Participants in Late-Stage Covid Vaccine Trial

Rebecca Urena12/18/2020

3222

Johnson & Johnson (NYSE: JNJ) announced Thursday it has enrolled approximately 45,000 participants for the first late-stage trial of its COVID-19 single-dose vaccine. The company anticipates provisional data by...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Mydecine Innovations (OTC: MYCOF) (CSE: MYCO) Engages ProPharma Group

financial buzz12/15/2020

2052

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel...

Breaking News Healthcare Investing News Life Style Market News The Market Buzz

Breaking News: Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

financial buzz12/15/2020

3810

Mydecine Innovations Group (OTC: MYCOF) (CSE: MYCO), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use,...

Biotechnology Breaking News Healthcare Life Style Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Sonoma Pharmaceuticals (NASDAQ: SNOA) Enters Partnership with Crown Laboratories

financial buzz12/11/2020

2542

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Sonoma Pharmaceuticals Enters Partnership with Crown Laboratories” Sonoma Pharmaceuticals (NASDAQ: SNOA) soared over 112% in premarket trading on...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical The Market Buzz

Oxford-AstraZeneca Vaccine Receives Green Light from Researchers

Rebecca Urena12/08/202012/08/2020

2704

AstraZeneca (OTCMKTS: AZNCF), a British-Swedish multinational pharmaceutical, along with Oxford University created a coronavirus vaccine which is the first to have its late-stage trial results independently reviewed and published...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Retail The Market Buzz Your Environment

Kroger Set to Administer COVID Vaccinations Once Approved

Rebecca Urena12/04/2020

1950

After reporting better than anticipated third quarter results on Thursday, Kroger (NYSE: KR) CEO, Rodney McMullen, spoke on the matter of coronavirus vaccines being administered within its pharmacies and...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Technology The Market Buzz Your Environment

AstraZeneca’s Oxford Coronavirus Vaccine Proven to be Effective and Affordable

Rebecca Urena11/23/2020

16447

AstraZeneca (OTCMKTS: AZNCF), the Swedish pharmaceutical, along with the University of Oxford have developed a trial coronavirus vaccine that is being praised for being “highly” protective. Ultimately, the vaccine...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Merck Enters Agreement to Acquire OncoImmune in Pursuit of Covid Drug

Rebecca Urena11/23/2020

20054

Merck (NYSE: MRK), an American pharmaceutical, is set to purchase privately held OncoImmune for a total of USD425 Million cash. The acquisition will grant it rights to a low...

Tag: pharmaceutical